VisionCare's first-of-kind telescope implant is integral to a new patient care program ... provide highly significant improvements in both vision and quality of life in patients living with ...

Graybug Vision, a Phase 2 biotech developing transformative medicines for ocular diseases, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The company's lead ...